Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Rheumatology in a COVID & Post-COVID World

Christopher Phillips, MD  |  

Christopher Phillips, MD, balances time with his solo private practice in Paducah, Ky., to help rheumatologists fight insurance battles for their patients in his role as chair of the ACR’s Insurance Subcommittee (ISC).

References

ADVERTISEMENT
SCROLL TO CONTINUE
  1. Hamburger MI. COVID-19 threatens rheumatology practices amid plunging patient volume, revenue. Healio Rheumatology. 2020 Apr 17.
  2. COVID-19 financial impact on medical practices (survey). MGMA. 2020 Apr 7–8.
  3. Feuer W. US isn’t prepared for outbreak. This is a ‘coronavirus winter, and we’re in the first week,’ disease specialist says. CNBC. 2020 Mar 10.
  4. Medicare telemedicine health care provider fact sheet. CMS.gov. 2020 Mar 17.
  5. Guidance to states: Lifting restrictions to extend the capacity of the health care workforce during the COVID-19 national emergency. National Council of State Boards of Nursing. (no date)
  6. Azar AM II. Letter to governors. Secretary of Health and Human Services. 2020 Mar 24.
  7. States waiving of modifying licensure requirements for telemedicine in response to COVID-19. American College of Rheumatology. 2020 Apr 24.
  8. Hollander JE, Sites FD. The transition from reimagining to recreating health care is now (letter). NEJM Catalyst. 2020 Apr 8.
  9. Telemedicine policies: Board by board overview. Federation of State Medical Boards. 2019 Nov.
  10. Guiding principles from the American College of Rheumatology for home infusion during the COVID-19 pandemic. American College of Rheumatology. 2020 Apr 11.
  11. ACR infusion guidance during COVID-19 crisis. American College of Rheumatology. 2020 Apr 11.
  12. Minemyer P. COVID-19 job losses could drive down employer plan enrollment by as much as 35M, report shows. Fierce Healthcare. 2020 Apr 3.
  13. Livingston S. COVID-19 could prompt higher 2021 insurance premiums, benefit cuts. Modern Healthcare. 2020 Mar 23.
  14. Paycheck protection program overview. American College of Rheumatology. 2020 Apr 24 (updated).
  15. HHS emergency fund disbursements to practices. American College of Rheumatology. 2020 Apr 20 (updated).
  16. Lane JCE, Weaver J, Kostka K, et al. Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: A multinational, network cohort and self-controlled case series study (preprint). medRxiv. 2020 Apr 10.
  17. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. FDA Drug Safety Communication. U.S. Food & Drug Administration. 2020 Apr 24.

*Name changed to preserve anonymity

Related Articles

    Telehealth Brings Opportunities to Enhance Patient Care

    During an ACR webinar in August, presenters discussed multiple aspects of telehealth in rheumatology, especially related to rheumatology fellowship training. They agreed that although telehealth represents one potential avenue to improve patient access to treatment for rheumatic disease, we must keep identifying the best ways to employ telehealth to enhance care. Impact of Pandemic Telemedicine…

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

    Telerheumatology: What’s Next?

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…